Clinical tolerance to lactose in children with cow's milk allergy

被引:34
作者
Fiocchi, A
Restani, P
Leo, G
Martelli, A
Bouygue, GR
Terracciano, L
Ballabio, C
Valsasina, R
机构
[1] Melloni Hosp, Dept Child & Maternal Med, I-20129 Milan, Italy
[2] Buzzi Hosp, Dept Paediat, Milan, Italy
[3] Univ Milan, Dept Pharmacol Sci, I-20122 Milan, Italy
[4] Ctr Studi Humana, Milan, Italy
关键词
children; lactose; cow's milk allergy; soy;
D O I
10.1542/peds.112.2.359
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective. Adverse reactions following the ingestion of lactose have been reported in children with cow's milk (CM) allergy. Whether this is attributable to the contamination of lactose with CM proteins is unknown. In this paper, we assessed clinical tolerance of lactose derived from CM whey in children hypersensitive to CM from 2 university hospital pediatric departments. Design. Twenty-four children (5 girls and 19 boys, median 25 months old; range: 2-107 months) with immediate CM allergy confirmed at history or during double-blind, placebo-controlled food challenge (DBPCFC) were enrolled. DBPCFC with CM could be conducted in 11 of 24 patients. Children with a history of immediate/delayed reactions to soy formula (SF) were excluded. Clinical tolerance to CM, SF, and SF + lactose was assessed by: 1) skin prick test with casein, lactalbumin, soy commercial allergen preparations, fresh CM, SF, SF and lactose, lactose (Official Pharmacopoeia) in 4 concentrations (0.01%, 0.1%, 1%, 10%); 2) specific serum immunoglobulin E determination by CAP system technology; 3) DBPCFC in 8 incremental doses of SF + lactose and using SF as a placebo to make up a total of 240 mL of reconstituted formula. Results. With a positive cutoff point of greater than or equal to3 mm wheal diameter at SPT, all patients were sensitized to fresh CM, lactalbumin, and/or casein. Twenty-three of 24 patients (95.8%) were SPT-positive to CM formula, 16 of 24 to lactalbumin (66.6%), 14 of 24 to casein (58.3%), and none to SF, SF + lactose, or lactose alone at all dilutions. Complexed immunoglobulin E determinations were positive for CM in 23 of 24 cases and negative in all cases for soy. Challenge with SF + lactose was negative in all cases. Conclusions. Even children hypersensitive to CM are clinically tolerant to lactose and can safely consume foods and drugs with lactose from bovine sources as an ingredient. Lactose exclusion is unwarranted from soy preparations on grounds of potential allergic reactions to CM protein residue.
引用
收藏
页码:359 / 362
页数:4
相关论文
共 13 条
  • [1] BOCK SA, 1997, FOOD ALLERGY ADVERSE, P161
  • [2] *COM NUTR SOC FRAN, 2001, ARCH PEDIATR, V8, P1226
  • [3] Lactose malabsorption and intolerance and peak bone mass
    Di Stefano, M
    Veneto, G
    Malservisi, S
    Cecchetti, L
    Minguzzi, L
    Strocchi, A
    Corazza, GR
    [J]. GASTROENTEROLOGY, 2002, 122 (07) : 1793 - 1799
  • [4] Dietary products used in infants for treatment and prevention of food allergy. Joint statement of the European Society for Paediatric Allergology and Clinical Immunology (ESPACI) Committee on Hypoallergenic Formulas and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Committee on Nutrition
    Host, A
    Koletzko, B
    Dreborg, S
    Muraro, A
    Wahn, U
    Aggett, P
    Bresson, JL
    Hernell, O
    Lafeber, H
    Michaelsen, KF
    Micheli, JL
    Rigo, J
    Weaver, L
    Heymans, H
    Strobel, S
    Vandenplas, Y
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1999, 81 (01) : 80 - 84
  • [5] KOERNER CB, 1991, FOOD ALLERGY ADVERSE, P332
  • [6] IMPROVED STAINING OF PROTEINS IN POLYACRYLAMIDE GELS INCLUDING ISOELECTRIC-FOCUSING GELS WITH CLEAR BACKGROUND AT NANOGRAM SENSITIVITY USING COOMASSIE BRILLIANT BLUE G-250 AND R-250
    NEUHOFF, V
    AROLD, N
    TAUBE, D
    EHRHARDT, W
    [J]. ELECTROPHORESIS, 1988, 9 (06) : 255 - 262
  • [7] EVALUATION BY SDS-PAGE AND IMMUNOBLOTTING OF RESIDUAL ANTIGENICITY IN HYDROLYZED PROTEIN FORMULAS
    RESTANI, P
    VELONA, T
    PLEBANI, A
    UGAZIO, AG
    POIESI, C
    MURARO, A
    GALLI, CL
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 1995, 25 (07) : 651 - 658
  • [8] RESTANI P, 1995, CLIN EXP ALLERGY, V25, P131
  • [9] Riva E, 2001, ARCH DIS CHILD, V84, P91
  • [10] Roger A, 1995, Allergol Immunopathol (Madr), V23, P133